▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3093 by analyst upside · 2026-08-13
RXST
RxSight, Inc.
Healthcare · Market Cap $294M · P/E 0x
ANALYST PRICE TARGET
+10.3%
implied upside to consensus target
Current Price $7.06
Consensus Target $7.79
Bull Target $11.0
Bear Target $6.0
Analysts Covering 8
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
0
Hold
6
Sell
1
52-Week Low $4.48
52-Week High $13.22
YTD Return -32.0%
FUNDAMENTALS
Market Cap $294M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.14
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $128M
Profit Margin -36.8%
52-WEEK RANGE
52-Week Low $4.48
52-Week High $13.22
Current Price $7.06
Bear Target $6.0
Bull Target $11.0
● Now $7.06 ● Target $7.79
TRADING DATA
Avg Volume 1.1M
YTD Return -32.0%
Analyst Count 8
Consensus Hold
Upside to Target +10.3%
Last Updated 2026-08-13

ANALYST SUMMARY

RxSight, Inc. (RXST) is currently trading at $7.06 with a Wall Street consensus price target of $7.79, implying potential upside of 10.3% over the next 12 months. 8 analysts currently cover RXST, with a consensus rating of Hold - 12% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $11.0, while the most cautious has a target of $6.0.

RXST operates in the Healthcare sector with a market capitalisation of $294M. The stock is down 32.0% year-to-date and is currently trading near the lower end of its 52-week range of $4.48 – $13.22.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

EMBC -15.8%
Embecta Corp.
$269M · P/E 3.2x · Hold
CYH +9.2%
Community Health Systems, Inc.
$410M · P/E 1.6x · Hold
SPOK +27.5%
Spok Holdings, Inc.
$230M · P/E 19.3x · Hold
PDEX +3.8%
Pro-Dex, Inc.
$215M · P/E 18.3x · Buy
VMD +18.8%
Viemed Healthcare, Inc.
$353M · P/E 25.7x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for RXST, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-05-07 Building track record
Needham - Reiterated
Buy → Buy 2026-05-07 20% win rate (5 calls)
Stifel - Reiterated
Hold → Hold 2026-03-09 Building track record
UBS - Reiterated
Neutral → Neutral 2026-02-26 33% win rate (6 calls)
Piper Sandler - Reiterated
Neutral → Neutral 2026-02-26 14% win rate (7 calls)
Needham reit
Buy → Buy 2026-02-26 20% win rate (5 calls)
Piper Sandler - Reiterated
Neutral → Neutral 2026-01-20 14% win rate (7 calls)
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2025-12-02 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
35
out of 100
Coverage depth
17/30
Consensus clarity
16/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →